Results 21 to 30 of about 34,976 (197)
Pulsating Enophthalmos in Neurofibromatosis Type 1
Medicine Science, 2015 Neurofibromatosis type 1 (NF-1) is a neurocutaneous syndrome with multisystem involvement, especially the central nervous system, eyes, and skin. In this article, we describe a patient with NF-1 with radiologically-imaged sphenoid wing aplasia that led ...
Yildiray Yildirim +4 more
doaj +1 more source
Neurofibromatosis: Types 1 and 2 [PDF]
American Journal of Neuroradiology, 2013 Neurofibromatosis types 1 and 2 are a group of neurocutaneous syndromes resulting from disorders in cell regulation. Despite sharing a common name, neurofibromatosis types 1 and 2 are quite distinct phakomatoses, both clinically and genetically.
S, Borofsky, L M, Levy
openaire +2 more sources
MRI Analysis of Neurofibromatosis Type 1
Pediatric Neurology Briefs, 1998 Serial MRI scans of 30 patients (mean age, 12 years) with neurofibromatosis Type 1 (NF-1) showed the evolution of high-signal brain lesions in a prospective study at the University of Connecticut Health Center, Farmington, and Children’s Medical Center ...
J Gordon Millichap
doaj +1 more source
MedCommNeurofibromatosis type 1 (NF1) is characterized by the development of benign plexiform neurofibromas (PNFs). In 10%–15% of patients, these tumors undergo malignant transformation into aggressive malignant peripheral nerve sheath tumors (MPNSTs).
Ling‐Ling Ge +11 more
doaj +1 more source
Lisch Nodules in Neurofibromatosis Type 1
Pediatric Neurology Briefs, 1991 The prevalence of Lisch nodules among 167 patients with neurofibromatosis 1 is reported from the Department of Pediatrics, Genetics Division, Miami Children’s Hospital, Miama, FL.
J Gordon Millichap
doaj +1 more source
Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine +17 more
wiley +1 more source
Learning Disabilities in Neurofibromatosis Type 1
Pediatric Neurology Briefs, 2006 The frequency of specific leaning disabilities (SLD) in neurofibromatosis type 1 (NF1) was determined in a cohort of 81 patients (43 males, 38 females; mean age 11 years 6 months; age range 8-16) followed at Children's Hospital, Westmead, NSW, Australia.
J Gordon Millichap
doaj +1 more source
Organoids in pediatric cancer research
FEBS Letters, EarlyView.Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley +1 more source
npj Digital MedicineDeep-learning models have shown promise in differentiating between benign and malignant lesions. Previous studies have primarily focused on specific anatomical regions, overlooking tumors occurring throughout the body with highly heterogeneous whole-body
Cheng-Jiang Wei +12 more
doaj +1 more source
Vascular Abnormalties in Neurofibromatosis Type 1
Pediatric Neurology Briefs, 2005 The spectrum of cerebrovascular abnormalities (CVA), including moyamoya, was evaluated in a retrospective chart review of 353 patients with neurofibromatosis type 1 (NF1) seen at the Children’s National Medical Center, Washington, DC, from 1995 to 2003.
J Gordon Millichap
doaj +1 more source